//
A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve Replacement
Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries
Left Ventricular Rapid Pacing Via the Valve Delivery Guidewire in Transcatheter Aortic Valve Replacement
Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve Replacement
Incidence and Outcomes of Surgical Bailout During TAVR : Insights From the STS/ACC TVT Registry
Prevalence and Outcomes of Concomitant Aortic Stenosis and Cardiac Amyloidosis
The Utility of Rapid Atrial Pacing Immediately Post-TAVR to Predict the Need for Pacemaker Implantation
Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial